Making sense of the many treatment options for relapsed MM: cost-effectiveness
There are now many options to treated relapsed/refractory multiple myeloma (MM); however, these drugs can be costly, and access differs between countries and locations. In this interview, Jean-Luc Har...
Author: VJHemOnc
Added: 05/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Myeloma